Sionna Therapeutics
SION· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Michael Cloonan, M.B.A. is the CEO of Sionna Therapeutics and was paid $7.0M in FY2025 (Dec), up 87%.
PayNo stock prices for these years
Executives3
See all- 1Michael Cloonan, M.B.A.President and Chief Executive OfficerFY2025
- 2Caroline Stark Beer, M.B.A.Chief Business OfficerFY2025
- 3Elena Ridloff, C.F.A.Chief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allSionna Therapeutics paid its 3 named executives $15.4M in total in FY2025 (Dec). CEO Michael Cloonan, M.B.A. was paid $7.0M of that.
| Name | |||
|---|---|---|---|
| Michael Cloonan, M.B.A.President and Chief Executive Officer | |||
| Caroline Stark Beer, M.B.A.Chief Business Officer | Not disclosed | ||
| Elena Ridloff, C.F.A.Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Sionna Therapeutics. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Peter A. Thompson, M.D.Director · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings4
See all| Proxy statement | DEF 14A | Apr 27, 2026 | FY2025 |
| Annual report | 10-K | Mar 2, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
